Literature DB >> 48056

Asthma mortality associated with pneumothorax and intermittent positive-pressure breathing.

M S Karetzky.   

Abstract

Many patients with acute asthma are treated with intermittent positive-pressure breathing (I.P.P.B.) devices. The development of pneumothorax in two fatal cases and its association with I.P.P.B suggests that this complication may be an important hazard in the treatment of acute asthma.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 48056     DOI： 10.1016/s0140-6736(75)93003-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  4 in total

1.  Allergy-epitomes of progress: emergency room treatment of the adult asthmatic.

Authors:  A I Terr
Journal:  West J Med       Date:  1978-09

2.  Editorial: Is intermittent positive pressure breathing therapy (IPPB RX) necessary in the surgical patient?

Authors:  M I Gold
Journal:  Ann Surg       Date:  1976-07       Impact factor: 12.969

Review 3.  A critique of dosing strategies for beta-2 adrenergic agents and theophylline.

Authors:  J W Jenne
Journal:  Lung       Date:  1981       Impact factor: 2.584

4.  Long-term risk of pneumothorax in asthmatic children: A 12-year population-based cohort study.

Authors:  Chien-Heng Lin; Cheng-Li Lin; Wei-Ching Lin; Chang-Ching Wei
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.